(Q37792862)

English

Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease

scientific article published on 25 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Crohn's disease

0 references

Edward V Loftus

object named as

Edward V Loftus

7

0 references

William Jeffery Sandborn

6

object named as

William J Sandborn

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

object named as

Eric J Dozois

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

Basil S Nasir

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Robert R Cima

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

John H Pemberton

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Bruce G Wolff

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

David W Larson

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

25 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1859-65; discussion 1865-6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab, azathioprine, or combination therapy for Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Crohn's disease in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of refractory inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab prevents Crohn's disease recurrence after ileal resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Certolizumab pegol for the treatment of Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab for active Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In flux on infliximab: conflicting studies on surgical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11605-010-1341-5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37792862&oldid=2200955445"